Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.480
+0.060 (4.23%)
At close: Apr 28, 2026, 4:00 PM EDT
1.490
+0.010 (0.68%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Autolus Therapeutics stock have an average target of 8.50, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 474.32% from the current stock price of 1.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +575.68% | Apr 9, 2026 |
| Mizuho | Mizuho | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +575.68% | Mar 31, 2026 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +575.68% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +508.11% | Feb 17, 2026 |
| Needham | Needham | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +575.68% | Jan 12, 2026 |
Financial Forecast
Revenue This Year
135.94M
from 75.39M
Increased by 80.32%
Revenue Next Year
209.29M
from 135.94M
Increased by 53.96%
EPS This Year
-0.93
from -1.08
EPS Next Year
-0.75
from -0.93
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 156.3M | 273.3M | ||||||
| Avg | 135.9M | 209.3M | ||||||
| Low | 116.4M | 141.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 107.3% | 101.0% | ||||||
| Avg | 80.3% | 54.0% | ||||||
| Low | 54.4% | 3.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.59 | -0.45 | ||||||
| Avg | -0.93 | -0.75 | ||||||
| Low | -1.31 | -0.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.